IGM Biosciences goes with the industry leader and selects R&D Logic's R&D Time for project time collection!
December 2016 — Located in Mountain View, CA, IGM Biosciences is dedicated to helping patients world-wide by creating and developing novel IgM and IgA antibodies which improve the treatment of cancer and infectious diseases.
Cerecor joins the R&D Logic customer community.
September 2016 — Located in Baltimore, MD, Cerecor Inc. joins the growing list of Biotech and Pharmaceutical companies convinced that doing business with a software company dedicated to life sciences is the right choice. Cerecor Inc. is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.
R&D Logic's R&D Time is the software of choice for Intellia Therapeutics for project time collection and FTE reporting.
July 2016 — Located in Cambridge, MA, Intellia Therapeutics is the most recent Biotech company to recognize R&D Logic's unique life sciences specialization. Intellia's combination of deep scientific expertise and clinical development experience, along with their leading intellectual property portfolio, puts them in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products.
R&D Logic is a proud sponsor of the 2016 ABFO National Conference.
May 2016 — This years conference will be held in San Diego from May 24th - 27th.
Spero Therapeutics, Inc. has chosen the R&D Logic platform for project time collection, project costing and FTE reporting.
April 2016 — Located in Cambridge, MA, Spero Therapeutics is the latest life science company to select R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Spero's mission is to develop, and advance groundbreaking therapeutics to meet critical patient needs in infectious disease.
R&D Logic's life science focused software suite has been selected by Karyopharm Therapeutics, Inc. for planning, project costing, time collection and reporting.
April 2016 — Located in Newton, MA, Karyopharm Therapeutics is the latest life science company in this explosive Biotech hub to select the R&D Logic solution to manage their R&D intensive company. Karyopharm's mission is to discover and develop first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
Balance Therapeutics, Inc. selects the R&D Logic platform for project time collection and FTE reporting.
March 2016 — Located in San Bruno, CA, Balance Therapeutics has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Balance is focused on developing therapeutics to address neurological disabilities resulting from excess inhibition of the brain.
Nurix, Inc. selects the R&D Logic platform for project time collection, FTE reporting and project costing.
January 2016 — Located in San Francisco, CA, Nurix has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Nurix is passionate in its mission of pioneering the development of small molecules that modulate the ubiquitin proteasome system (UPS) for improvement of human health.